Payment overview · 2025
General Payments
$190.71
27 reported records · 2 companies
Healthcare provider profile · identity verified
Steven Frederick Hill, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · SOUTH BEND, WA · NPI 1104875962
Verified facts
What the public records show
CMS Open Payments records show Steven Frederick Hill, D.O. received $190.71 in general payments during 2025 across 27 reported records.
PFIZER INC. accounted for 85.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Abrysvo.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 327 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $163.37 | 85.7% | 26 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $27.34 | 14.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $190.71 | 27 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $128.70 | 24 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $128.70 | 24 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $27.34 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $18.73 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $18.73 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $18.73 | 1 | 2025 |
Source payment records
|
|||||
| VYNDAMAX Normalized: vyndamax |
Drug | PFIZER INC. | $15.94 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ABRYSVO abrysvo |
2025 | Abrysvo | 2024 | 14 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
14 | 14 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
327 | 54 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 818 | 185 |
| Metoprolol Succinate | Metoprolol Succinate | 616 | 123 |
| Lisinopril | Lisinopril | 600 | 141 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 566 | 74 |
| Losartan Potassium | Losartan Potassium | 527 | 113 |
| Omeprazole | Omeprazole | 481 | 108 |
| Levothyroxine Sodium | Levothyroxine Sodium | 441 | 102 |
| Potassium Chloride | Potassium Chloride | 388 | 95 |
| Amlodipine Besylate | Amlodipine Besylate | 356 | 90 |
| Furosemide | Furosemide | 349 | 79 |
| Eliquis | Apixaban | 327 | 54 |
| Gabapentin | Gabapentin | 324 | 74 |
| Glimepiride | Glimepiride | 306 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 268 | 55 |
| Metformin Hcl Er | Metformin Hcl | 244 | 47 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 228 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 227 | 54 |
| Oxycodone Hcl | Oxycodone Hcl | 224 | 35 |
| Allopurinol | Allopurinol | 223 | 46 |
| Metformin Hcl | Metformin Hcl | 208 | 48 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 204 | 51 |
| Metoprolol Tartrate | Metoprolol Tartrate | 203 | 39 |
| Baclofen | Baclofen | 202 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 169 | 44 |
| Pioglitazone Hcl | Pioglitazone Hcl | 161 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 160 | 28 |
| Trazodone Hcl | Trazodone Hcl | 159 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 154 | 35 |
| Jardiance | Empagliflozin | 154 | 31 |
| Simvastatin | Simvastatin | 150 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 147 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 140 | 27 |
| Atenolol | Atenolol | 130 | 29 |
| Donepezil Hcl | Donepezil Hcl | 115 | 19 |
| Carvedilol | Carvedilol | 100 | 31 |
| Diclofenac Sodium | Diclofenac Sodium | 99 | 34 |
| Famotidine | Famotidine | 98 | 19 |
| Montelukast Sodium | Montelukast Sodium | 95 | 18 |
| Alprazolam | Alprazolam | 92 | 15 |
| Sertraline Hcl | Sertraline Hcl | 91 | 18 |
| Celecoxib | Celecoxib | 87 | 17 |
| Tramadol Hcl | Tramadol Hcl | 87 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 79 | 16 |
| Lovastatin | Lovastatin | 76 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 73 | 22 |
| Xarelto | Rivaroxaban | 73 | suppressed |
| Finasteride | Finasteride | 69 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 68 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 65 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 65 | 14 |
| Ventolin Hfa | Albuterol Sulfate | 63 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 61 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 61 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 60 | 15 |
| Lorazepam | Lorazepam | 60 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 59 | 17 |
| Sucralfate | Sucralfate | 58 | 11 |
| Methylprednisolone | Methylprednisolone | 56 | 49 |
| Warfarin Sodium | Warfarin Sodium | 56 | 12 |
| Clonidine Hcl | Clonidine Hcl | 55 | 12 |
| Spironolactone | Spironolactone | 55 | 12 |
| Torsemide | Torsemide | 55 | suppressed |
| Prednisone | Prednisone | 54 | 29 |
| Bumetanide | Bumetanide | 53 | suppressed |
| Clonazepam | Clonazepam | 52 | suppressed |
| Digoxin | Digoxin | 52 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 52 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 49 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 48 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 48 | 15 |
| Topiramate | Topiramate | 48 | suppressed |
| Prenatal Vitamin Plus Low Iron | Pnv,calcium 72/Iron/Folic Acid | 47 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 46 | 11 |
| Januvia | Sitagliptin Phosphate | 46 | suppressed |
| Diazepam | Diazepam | 45 | suppressed |
| Glipizide | Glipizide | 45 | 12 |
| Bupropion Xl | Bupropion Hcl | 43 | 14 |
| Ezetimibe | Ezetimibe | 42 | 13 |
| Meloxicam | Meloxicam | 42 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 41 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 41 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 39 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 38 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 37 | suppressed |
| Mirtazapine | Mirtazapine | 35 | suppressed |
| Risperidone | Risperidone | 35 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 34 | 33 |
| Benazepril Hcl | Benazepril Hcl | 33 | suppressed |
| Fluconazole | Fluconazole | 33 | 14 |
| Memantine Hcl | Memantine Hcl | 33 | suppressed |
| Nabumetone | Nabumetone | 33 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 33 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 32 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 32 | suppressed |
| Pregabalin | Pregabalin | 32 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Lamotrigine | Lamotrigine | 30 | suppressed |
| Olanzapine | Olanzapine | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 25 |
| Bupropion Hcl Sr | Bupropion Hcl | 29 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 29 | suppressed |
| Carbamazepine Er | Carbamazepine | 27 | suppressed |
| Cephalexin | Cephalexin | 27 | 22 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 23 |
| Farxiga | Dapagliflozin Propanediol | 26 | suppressed |
| Fenofibrate | Fenofibrate | 26 | suppressed |
| Ozempic | Semaglutide | 26 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Azithromycin | Azithromycin | 25 | 22 |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Nystatin | Nystatin | 25 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | 11 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 25 | 24 |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 24 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Cefprozil | Cefprozil | 21 | 19 |
| Estradiol | Estradiol | 21 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 21 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 19 | suppressed |
| Insulin Lispro Protamine Mix | Insulin Lispro Protamin/Lispro | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 18 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | 12 |
| Methocarbamol | Methocarbamol | 16 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Carisoprodol | Carisoprodol | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 15 |
| Nitroglycerin | Nitroglycerin | 15 | 11 |
| Tradjenta | Linagliptin | 15 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 14 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 13 | 13 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 13 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Asmanex | Mometasone Furoate | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Dofetilide | Dofetilide | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Ciclopirox | Ciclopirox | 11 | suppressed |
| Felodipine Er | Felodipine | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $190.71 · 27 records | PFIZER INC. | ABRYSVO, COMIRNATY, Dexcom G6 Transmitter, NURTEC ODT, PREVNAR 20, VYNDAMAX, ZAVZPRET | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Abrysvo play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error